Board of Directors


The Board of Directors (“the Board”) of Wang-Zheng Berhad (“Wang-Zheng” or “the Company”) believes that good corporate governance is fundamental to the Wang-Zheng Berhad of Companies (“the Group”) continued success. Therefore, the Board is committed to ensuring that highest standards of Corporate Governance are practiced throughout Wang-Zheng, as a fundamental part of discharging its responsibilities to protect and enhance the shareholders’ value and financial performance of the organisation.

Hui Lin Chit

Aged 65 | Male | Chinese
Non-Independent Non-Executive Chairman
Chairman of Remuneration Committee

Mr. Hui Lin Chit was appointed to the Board as Executive Director on 15 June 2017. Subsequently, Mr. Hui was redesignated as Non-Independent Non-Executive Chairman on 25 September 2017.

Read More

Goh Kheng Jiu

Aged 59 | Male | Malaysian
Managing Director and Chief Executive Officer

Mr. Goh Kheng Jiu was appointed to the Board as the Managing Director and Chief Executive Officer of Wang-Zheng on 16 July 2004. Mr. Goh oversees the daily operations and strategizes the business directions of Wang-Zheng Berhad.

Read More

Hui Ching Chi

Aged 34 | Male | Chinese
Executive Director

Mr. Hui Ching Chi was appointed to the Board as Executive Director on 25 September 2017. Mr. Hui is the Executive Director of Hengan International. Mr. Hui holds a Law Degree from the London University.

Read More

Li Wai Leung

Aged 41 | Male | Chinese
Executive Director

Mr. Li Wai Leung was appointed to the Board as Executive Director on 15 June 2017. Mr. Li obtained his bachelor’s degree in Business Administration in Accounting and Finance from the University of Hong Kong.

Read More

Nancy Wong Pui Wai

Aged 37 | Female | Chinese
Executive Director

Ms. Nancy Wong Pui Wai was appointed to the Board as Executive Director on 25 September 2017. Ms. Wong was appointed as the Managing Director of the Hengan Pharmacare Co., Ltd, an indirect subsidiary of Hengan International in 2016.

Read More

Sze Man Bok

Aged 69 | Male | Chinese
Non-Independent Non-Executive Director
Chairman of Nomination Committee

Mr. Sze Man Bok was appointed to the Board as Executive Director on 15 June 2017. Subsequently, Mr. Sze was redesignated as Non-Independent Non-Executive Director on 25 September 2017.

Read More

Hui Lin Chit

Aged 65 | Male | Chinese
Non-Independent Non-Executive Chairman
Chairman of Remuneration Committee

Mr. Hui Lin Chit was appointed to the Board as Executive Director on 15 June 2017. Subsequently, Mr. Hui was redesignated as Non-Independent Non-Executive Chairman on 25 September 2017.

Read More

Goh Kheng Jiu

Aged 59 | Male | Malaysian
Managing Director and Chief Executive Officer

Mr. Goh Kheng Jiu was appointed to the Board as the Managing Director and Chief Executive Officer of Wang-Zheng on 16 July 2004. Mr. Goh oversees the daily operations and strategizes the business directions of Wang-Zheng Berhad.

Read More

Hui Ching Chi

Aged 34 | Male | Chinese
Executive Director

Mr. Hui Ching Chi was appointed to the Board as Executive Director on 25 September 2017. Mr. Hui is the Executive Director of Hengan International. Mr. Hui holds a Law Degree from the London University.

Read More

Li Wai Leung

Aged 41 | Male | Chinese
Executive Director

Mr. Li Wai Leung was appointed to the Board as Executive Director on 15 June 2017. Mr. Li obtained his bachelor’s degree in Business Administration in Accounting and Finance from the University of Hong Kong.

Read More

Nancy Wong Pui Wai

Aged 37 | Female | Chinese
Executive Director

Ms. Nancy Wong Pui Wai was appointed to the Board as Executive Director on 25 September 2017. Ms. Wong was appointed as the Managing Director of the Hengan Pharmacare Co., Ltd, an indirect subsidiary of Hengan International in 2016.

Read More

Sze Man Bok

Aged 69 | Male | Chinese
Non-Independent Non-Executive Director
Chairman of Nomination Committee

Mr. Sze Man Bok was appointed to the Board as Executive Director on 15 June 2017. Subsequently, Mr. Sze was redesignated as Non-Independent Non-Executive Director on 25 September 2017.

Read More